Os efeitos terapêuticos do Elagolix e Danazol no tratamento de dor associado a endometriose
No Thumbnail Available
Date
2021-10
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Católica do Salvador
Abstract
Endometriosis is a chronic, estrogen-dependent inflammatory condition that affects 6 to 10%
of women of reproductive age. This article aims to clearly explain the pathogenesis of
endometriosis, presenting and comparing the effects of the chosen drugs, Elagolix and
Danazol, used as therapeutic measures for endometriosis-related pain. The information for
this study was obtained by searching for articles in Portuguese and English in the Scielo,
Pubmed and Medline databases, using as criteria those published within a maximum period
of 20 years. In conclusion, although Danazol is one of the oldest and most used standard
treatments for endometriosis, Elagolix, the new drug, is not only effective in the treatment, but
also has fewer adverse effects.
Description
Keywords
Endometriose, Danazol, Elagolix, Anticoncepcional oral, Endometriosis, Oral contraceptives, SEMOC - Semana de Mobilização Científica